Global Stable Isotope Labeled Biomolecules Market Research Report 2021

This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.

An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.
North America is the largest consumer by regions. North America accounted about 52.63% consumption market share in 2016. Europe is the second largest with 33.92% market share. China is the following consumption region with 5.53% consumption market share.

The global Stable Isotope Labeled Biomolecules market was valued at US$ 111 million in 2019 and is expected to reach US$ 135.9 million by the end of 2026, growing at a CAGR of 2.9% during 2021-2026.
This report focuses on Stable Isotope Labeled Biomolecules volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Stable Isotope Labeled Biomolecules market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Stable Isotope Labeled Biomolecules Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
Others

Segment by Application
Scientific Research
Medical
Industrial
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes

Frequently Asked Questions